NCT05669742
- Conditions
- Sodium-glucose Transport Protein Two Inhibitor (SGLT2),Metabolic Deficits Caused by Antipsychotics
- Locations
-
- Tanta Unuversity Tanta, Egypt
Clinical trial condition
Sodium-glucose Transport Protein Two Inhibitor (SGLT2),Metabolic Deficits Caused by Antipsychotics
Explore clinical trials studying Sodium-glucose Transport Protein Two Inhibitor (SGLT2),Metabolic Deficits Caused by Antipsychotics. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study